Protocolo para el uso institucional del medicamento tizanidina
| dc.contributor.author | Caja Costarricense de Seguro Social, Área de Medicamentos y Terapéutica Clínica | |
| dc.date.accessioned | 2024-08-09T17:28:43Z | |
| dc.date.available | 2024-08-09T17:28:43Z | |
| dc.date.issued | 2016-04-22 | |
| dc.description | CIRCULAR | es_ES |
| dc.description.abstract | Tizanidina | es_ES |
| dc.description.sponsorship | CCSS | es_ES |
| dc.identifier.other | DFE-AMTC-REC-0955-04-2016 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11764/4518 | |
| dc.language.iso | es | es_ES |
| dc.publisher | CCSS | es_ES |
| dc.subject | TIZANIDINA | es_ES |
| dc.title | Protocolo para el uso institucional del medicamento tizanidina | es_ES |
| dc.title.alternative | DFE-AMTC-REC-0955-04-2016 | es_ES |
| dc.type | Working Paper | es_ES |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- DFE-AMTC-REC-0955-04-2016 Protocolo para el uso institucional del medicamento tizanidina.pdf
- Size:
- 38.57 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 26 B
- Format:
- Item-specific license agreed upon to submission
- Description: